nonmedical terms through the library of NCCN Guidelines for Patients to empower people with cancer and their caregivers to better understand their management and participate in shared decision making. Both the clinical and patient guidelines are available for
Search Results
Guidelines for Patients provide a user-friendly look at the clinical information contained in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) in order to equip patients for shared decision-making with their health care providers. The
officer, NCCN. “NCCN Evidence Blocks will educate providers and patients about the efficacy, safety, and affordability of systemic therapy, serving as a starting point for shared decision-making based on the individual patient's value system.” The
The awardees responded to an RFP from NCCN ORP and Pfizer IGLC seeking concepts for initiatives focusing on the following areas where gaps in care currently exist: Provider education and provider/patient treatment shared decision-making Adoption
Rie Tamagawa, Shannon Groff, Jennifer Anderson, Sarah Champ, Andrea Deiure, Jennifer Looyis, Peter Faris, and Linda Watson
and responsive clinical interactions and shared decision-making, a core component of person-centered care. 15 Research indicates that routine SFD improves quality of care, such as patient–provider interactions, 16 and symptom management 17 ; however
Leigh Gallo, Ronald S. Walters, Jeff Allen, Jenny Ahlstrom, Clay Alspach, Yelak Biru, Alyssa Schatz, Kara Martin, and Robert W. Carlson
interoperability and encourage the aggregation of patient data that will promote shared decision-making and increase understanding between patients, providers, and payers. Access to personal health data empowers patients to make informed decisions about their
Michelle Guan, Gillian Gresham, Arvind Shinde, Isaac Lapite, Jun Gong, Veronica R. Placencio-Hickok, Christopher B. Forrest, and Andrew E. Hendifar
to improve shared decision-making between patients and physicians. However, there is limited research on the relevancies of the numerous available PROs to patients with PDAC and whether these align with what their physicians believe are patient
Stefanie L. Thorsness, Azael Freites-Martinez, Michael A. Marchetti, Cristian Navarrete-Dechent, Mario E. Lacouture, and Emily S. Tonorezos
cancer survivors who have in-field NMSC with low-risk histologic and clinical features, dermatologic therapy options with lower costs and risks should be considered in the shared decision-making process. Limitations of this study include a study
Christina D. Williams, William M. Grady, and Leah L. Zullig
screening rates are suboptimal, with at least one-third of eligible patients having never been screened, the USPSTF asserts that the “best screening test is the one that gets done.” Shared decision-making is an approach to choosing the “best” and preferred
Priya Wanchoo, Chris Larrison, Carol Rosenberg, Naomi Ko, Cynthia Cantril, Naomi Moeller, Ruchit Parikh, and Ana-Marija Djordjevic
order to identify perceived competency gaps ( Figure 1 ). Interestingly, the smallest perceived gaps in ability were related to engaging the patient in shared decision-making for therapy selection and communicating disease status or updating patients on